Intra-aortic balloon counterpulsation for the treatment of myocardial infarction complicated by acute severe heart failure

• Published in: Congestive heart failure (Greenwich, Conn.) Vol. 15; no. 1; p. 35
• Main Authors: Tsagalou, Eleftheria P, Anastasiou-Nana, Maria I, Nanas, John N
• Format: Journal Article
• Language: English
• Published: United States 01.01.2009
• Subjects: Heart Failure - etiology; Heart Failure - physiopathology; Heart Failure - therapy; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping - adverse effects; Intra-Aortic Balloon Pumping - methods; Myocardial Infarction - complications; Myocardial Infarction - physiopathology; Myocardial Infarction - therapy; Severity of Illness Index
• ISSN: 1751-7133
• DOI: 10.1111/j.1751-7133.2008.00033.x

Intractable heart failure (HF) remains a leading fatal complication of acute myocardial infarction (AMI). Intra-aortic balloon pump (IABP) counterpulsation assists the failing left ventricle and accelerates the functional recovery of stunned myocardium. Despite its remarkable performance, the beneficial effects of the IABP in the setting of acute HF or cardiogenic shock complicating AMI have not been confirmed in a randomized clinical trial. Instead, large amounts of information have been collected in observational studies or in retrospective analyses of randomized trials of reperfusion strategies in patients with AMI. The strategy of "stabilize with IABP, treat with reperfusion, and transfer for complete revascularization" has, thus far, yielded the best outcomes, and every effort should be made to implement this strategy in all patients presenting with AMI and severe HF.